AMG 386: Phase III ongoing

Takeda began the Japanese portion of the ongoing, double-blind, international Phase III TRINOVA-1 trial comparing weekly IV AMG 386 plus paclitaxel vs. placebo plus paclitaxel in about 900 patients. T...